| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 56.884 | 85.519 | 80.969 | 80.435 | 82.787 | - |
| Total Income - EUR | - | - | - | 0 | 57.091 | 86.109 | 81.337 | 80.456 | 82.787 | - |
| Total Expenses - EUR | - | - | - | 1.043 | 60.674 | 81.433 | 76.263 | 76.076 | 82.585 | - |
| Gross Profit/Loss - EUR | - | - | - | -1.043 | -3.583 | 4.676 | 5.075 | 4.380 | 202 | - |
| Net Profit/Loss - EUR | - | - | - | -1.043 | -4.153 | 4.047 | 4.278 | 3.696 | -626 | - |
| Employees | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Biorenicoplant S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 701 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | - | - | - | 448 | 12.955 | 15.747 | 21.146 | 24.471 | 7.073 | - |
| Inventories | - | - | - | 268 | 11.897 | 13.253 | 20.425 | 23.268 | 0 | - |
| Receivables | - | - | - | 1 | 4 | 0 | 217 | 59 | 972 | - |
| Cash | - | - | - | 179 | 1.054 | 2.494 | 504 | 1.145 | 6.100 | - |
| Shareholders Funds | - | - | - | -1.000 | -5.134 | -989 | 3.311 | 4.990 | 305 | - |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | 2.149 | 18.089 | 16.736 | 17.835 | 19.481 | 6.767 | - |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4776 - 4776" | |||||||||
| CAEN Financial Year |
4776
|
|||||||||
Comments - Biorenicoplant S.r.l.